HomeINVO • NASDAQ
add
Invo Bioscience Inc
Previous close
$1.30
Day range
$1.13 - $1.28
Year range
$0.50 - $10.50
Market cap
3.21M USD
Avg Volume
7.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 974.89K | 314.28% |
Operating expense | 1.28M | -49.03% |
Net income | -1.25M | 51.03% |
Net profit margin | -128.06 | 88.18% |
Earnings per share | — | — |
EBITDA | -865.79K | 65.45% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.06M | 269.46% |
Total assets | 19.48M | 316.31% |
Total liabilities | 19.10M | 463.35% |
Total equity | 372.80K | — |
Shares outstanding | 2.47M | — |
Price to book | 8.67 | — |
Return on assets | -16.97% | — |
Return on capital | -35.15% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.25M | 51.03% |
Cash from operations | -1.25M | 24.33% |
Cash from investing | -2.26M | -74,973.70% |
Cash from financing | 4.45M | 17,753.12% |
Net change in cash | 943.06K | 156.25% |
Free cash flow | -669.63K | 11.25% |
About
Founded
2007
Headquarters
Website
Employees
25